资金流向方面，主力资金净流入887.29万元，特大单买入122.83万元，占比0.52%，卖出486.57万元，占 比2.05%；大单买入3993.58万元，占比16.85%，卖出2742.56万元，占比11.57%。 万润股份今年以来股价涨19.16%，近5个交易日涨10.69%，近20日涨1.21%，近60日涨3.28%。 资料显示，中节能万润股份有限公司位于山东省烟台市经济技术开发区五指山路11号，成立日期1995年 7月5日，上市日期2011年12月20日，公司主营业务涉及从事电子信息材料产业、环保材料产业和大健康 产业三个领域产品的研发、生产和销售。主营业务收入构成为：功能性材料类78.58%，生命科学与医 药类20.09%，其他(补充)1.33%。 11月28日，万润股份盘中上涨2.09%，截至13:49，报14.18元/股，成交2.37亿元，换手率1.86%，总市值 130.88亿元。 截至9月30日，万润股份股东户数4.21万，较上期减少13.28%；人均流通股21575股，较上期增加 15.31%。2025年1月-9月，万润股份实现营业收入28.26亿元，同比增长2.31%；归母净利润3.0 ...

Company Overview - Wanrun Co., Ltd. is located in Yantai Economic and Technological Development Zone, Shandong Province, established on July 5, 1995, and listed on December 20, 2011 [1] - The company operates in three main business areas: electronic information materials, environmental protection materials, and health industry products, with revenue composition being 78.58% from functional materials, 20.09% from life sciences and pharmaceuticals, and 1.33% from other sources [1] Financial Performance - For the period from January to September 2025, Wanrun Co., Ltd. achieved a revenue of 2.826 billion yuan, representing a year-on-year growth of 2.31%, and a net profit attributable to shareholders of 306 million yuan, up 3.27% year-on-year [2] - Since its A-share listing, the company has distributed a total of 2.005 billion yuan in dividends, with 646 million yuan distributed over the past three years [3] Stock Performance - As of November 5, Wanrun's stock price decreased by 2.06%, trading at 13.32 yuan per share, with a total market capitalization of 12.294 billion yuan [1] - Year-to-date, the stock price has increased by 11.93%, but it has seen a decline of 4.79% over the last five trading days and a decrease of 3.13% over the last 20 days [1] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.28% to 42,100, while the average number of circulating shares per person increased by 15.31% to 21,575 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the ninth largest with 12.2602 million shares, an increase of 3.6845 million shares from the previous period [3]

Core Points - Wanrun Co., Ltd. experienced a stock price decline of 2.02% on November 4, trading at 13.61 CNY per share with a market capitalization of 12.561 billion CNY [1] - The company has seen a year-to-date stock price increase of 14.37%, but a decline of 2.65% over the last five trading days [1] Financial Performance - For the period from January to September 2025, Wanrun Co., Ltd. reported a revenue of 2.826 billion CNY, representing a year-on-year growth of 2.31% [2] - The net profit attributable to shareholders for the same period was 306 million CNY, reflecting a year-on-year increase of 3.27% [2] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.28% to 42,100, while the average number of circulating shares per person increased by 15.31% to 21,575 shares [2] - The company has distributed a total of 2.005 billion CNY in dividends since its A-share listing, with 646 million CNY distributed over the past three years [3] Ownership Structure - As of September 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder, increasing its holdings by 3.6845 million shares to 12.2602 million shares [3] - Guangfa Multi-Factor Mixed Fund became a new shareholder, holding 10.8781 million shares, ranking as the tenth largest circulating shareholder [3]

Group 1 - The core viewpoint of the news is that Wanrun Co., Ltd. has seen a significant increase in its stock price, with a rise of 5.11% to 13.79 CNY per share, and a total market capitalization of 12.728 billion CNY [1] - Wanrun Co., Ltd. is engaged in three main business areas: electronic information materials, environmental protection materials, and health industry products, with functional materials accounting for 78.58% of revenue, life sciences and pharmaceuticals for 20.09%, and other categories for 1.33% [1] Group 2 - From the perspective of fund holdings, one fund under Galaxy Fund has a significant position in Wanrun Co., Ltd., specifically the Galaxy New Materials Stock Initiation A (020276), which reduced its holdings by 5,800 shares in the second quarter, maintaining 53,700 shares, representing 5.26% of the fund's net value [2] - The Galaxy New Materials Stock Initiation A (020276) has achieved a year-to-date return of 32.29%, ranking 1479 out of 4220 in its category, and a one-year return of 62.93%, ranking 1436 out of 3814 [2] - The fund manager of Galaxy New Materials Stock Initiation A is Jin Ye, who has been in the position for approximately 3 years and 265 days, with the fund's total asset size at 54.3398 million CNY [3]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company's performance improved in the first half of 2025, with a year-on-year increase in net profit despite a slight decline in revenue. The second quarter showed a significant recovery in profitability [2][4]. - The company is actively expanding its production capacity in new materials, particularly in semiconductor manufacturing materials, which is expected to drive future growth [3][4]. Financial Performance Summary - In the first half of 2025, the company achieved revenue of 1.87 billion, a year-on-year decrease of 4.42%, while net profit attributable to shareholders was 218 million, an increase of 1.35% [2][6]. - For Q2 2025, revenue was 1.01 billion, with a year-on-year increase of 17.12%, and net profit was 138 million, reflecting a significant quarter-on-quarter growth of 73.13% [2][6]. - The gross margin for Q2 2025 was 39.77%, showing an improvement compared to previous periods, while the net margin reached 16.02% [2][3]. Business Segment Performance - The functional materials segment generated revenue of 1.47 billion, down 9.55% year-on-year, while the life sciences and pharmaceutical products segment saw a revenue increase of 20.80% to 376 million [2][3]. - The company is focusing on high-performance polymer products, with PEEK materials already in trial production and ongoing market promotion [3]. Future Outlook - The company expects to achieve net profits of 434 million, 519 million, and 581 million for the years 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 29.23, 24.44, and 21.80 [4][10]. - The ongoing construction of the new materials project is 55% complete, with plans to add 7,900 tons/year of functional materials capacity, which is anticipated to start production within the year [3][4].